Acylaminoalkyl-substituted benzenes- ulfonamide derivatives

Details for Australian Patent Application No. 2002218253 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Englert, Heinrich Christian; Heitsch, Holger

Agent Watermark

Pub. Number AU-B-2002218253

PCT Pub. Number WO02/36556

Priority 10054481 03.11.00 DE

Filing date 20 October 2001

Wipo publication date 15 May 2002

Acceptance publication date 6 July 2006

International Classifications

C07C 311/58 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 335/42 (2006.01) Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 215/54 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

6 July 2006 Application Accepted

  Published as AU-B-2002218253

2 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002218254

2002218252-MULTICAST TRANSMISSION TO A RADIO ACCESS NETWORK